New technology greatly enhances a retinal surgeon’s ability to provide enhanced care to retinal patients.
A machine, called the NGENUITY 3D VISUALIZATION SYSTEM has been developed which aligns perfectly with our Foundation’s goals of improved clinical care and enabling the education of future retinal surgeons. Read more about the system here.
Currently retinal surgeons hunch over a microscope and peer into an infinitely small space to do corrective surgery – drawbacks include a microscopic work area, an inability for students to see what is being done, and, not unimportantly, fatigue and back strain as surgeons have to bend over their microscopes for long periods of time.
This new instrument, powered by a 3 D high dynamic range camera and a 3 D 4 K OLED monitor creates a singular operating room experience, by redefining how surgical information is captured and displayed. It allows the surgeon to sit upright – no back strain; work in a significantly bigger work space; and share his actions with students can watch the screen as the procedure is being done. Simple in concept but transformational in practice.
Currently widely used in Europe, it is just now coming to North America. There is only one such machine in operation in Canada at the Hopital Notre Dame in Montreal. We wish to join with the Montreal General Hospital Foundation to finance the purchase of one of these machines, at a cost of $110,000 – each party is to provide 50% of the funds.
Retina Foundation of Canada, it gives us great pleasure to introduce Dr. Gallie as the one of the recipients of the 2017 Senior Clinical Research Grant of the Retina Foundation of Canada.
The value of the research grant is $20,000 for their project titled, “Liquid Biopsy for non-invasive genomic analysis of ocular tumours”.
The Retina Foundation of Canada is a national organization dedicated to fighting retinal disease and preserving vision. Supporting the efforts of Canadian researchers, who are investigating retinal diseases, has been one of the early initiatives of the Foundation.
Congratulations Dr. Gallie, we look forward to your research project and future publications or presentations.
Can a Retinal Examination Provide Clues to a Person’s Risk of Stroke?
To provide an update on recent studies on the epidemiology of retinal microvascular signs
To discuss the relationship of retinal microvascular signs with risk of stroke, stroke subtypes and other cerebrovascular diseases
To discuss the potential application of retinal imaging for clinical prediction of stroke
Provost Chair Professor, National University of Singapore;
Vice-Dean, Office of Clinical Sciences, Duke-NUS Graduate Medical School;
Group Director, Research, Singapore Health Services;
Senior Consultant Ophthalmologist, Singapore National Eye Centre;
Senior Principal Clinician-Scientist, Singapore
Professor Tien Y. Wong
Eye Research Institute
Date: Wednesday, May 21st
6:30 – 7:00: Reception
7:00 – 8:30: Conference and dinner
Where : Le Pois Penché Restaurant 1230, boul. De Maisonneuve O., Montreal
Please confirm your presence with Claudia Lachapelle at 514-237-8485
In compliance with the Rx&D Code of Conduct, this invitation is extended to health care
This program is supported in part by an educational grant from Novartis Canada Inc.
Dr. Jean Daniel Arbour, a retina surgeon, says existing ways of checking retinas, such as this conventional camera being used on patient Paul Lowery at Notre Dame Hospital, can see damage only after it has happened. He is pioneering a new method to detect the early signs of vision loss by using spectral photography. See the original article in the Montreal Gazette
Dr. Jean Daniel Arbour is a valued member of the Retina Foundation of Canada Medical Advisory Board.